Table 2 Hematological parameters associated with in-hospital mortality
Variable | Survivors n = 229 | Non-survivors n = 49 | p§ |
|---|---|---|---|
Median (IQR) | Median (IQR) | ||
WBC, *103/µL | 11 (7.2–15.2) | 12.9 (6.8–17.1) | 0.53 |
Neutrophils, *103/µL | 8.7 (4.9–13) | 10.6 (6.4–15.5) | 0.20 |
Lymphocytes, *103/µL | 1.1 (0.6–1.6) | 0.60 (0.3–1.1) |  < 0.001 |
Monocytes, *103/µL | 0.7 (0.4–0.9) | 0.5 (0.2–0.9) | 0.002 |
Platelet, *103/µL | 192 (138–262) | 154 (74–229) | 0.003 |
CD3 + T Lymphocytes, cells/µL | 673 (368–1,080) | 347 (188–536) |  < 0.001 |
CD4 + T Lymphocytes, cells/µL | 405 (222–661) | 197 (106–265) |  < 0.001 |
CD8 + T Lymphocytes, cells/µL | 268 (133–461) | 134 (87–231) |  < 0.001 |
CD16/56 + Lymphocytes, cells/µL | 34 (14–91) | 37 (16–106) | 0.66 |
CD19 + B Lymphocytes, cells/µL | 130 (67–227) | 76 (35–140) |  < 0.001 |